These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 21554154

  • 1. NADPH oxidase inhibitors: a patent review.
    Kim JA, Neupane GP, Lee ES, Jeong BS, Park BC, Thapa P.
    Expert Opin Ther Pat; 2011 Aug; 21(8):1147-58. PubMed ID: 21554154
    [Abstract] [Full Text] [Related]

  • 2. Advances and strategies in NADPH oxidase inhibitors and activators patents.
    Page P.
    Pharm Pat Anal; 2014 Jul; 3(4):387-409. PubMed ID: 25291313
    [Abstract] [Full Text] [Related]

  • 3. The NADPH oxidase family and its inhibitors.
    Kleniewska P, Piechota A, Skibska B, Gorąca A.
    Arch Immunol Ther Exp (Warsz); 2012 Aug; 60(4):277-94. PubMed ID: 22696046
    [Abstract] [Full Text] [Related]

  • 4. A subset of N-substituted phenothiazines inhibits NADPH oxidases.
    Seredenina T, Chiriano G, Filippova A, Nayernia Z, Mahiout Z, Fioraso-Cartier L, Plastre O, Scapozza L, Krause KH, Jaquet V.
    Free Radic Biol Med; 2015 Sep; 86():239-49. PubMed ID: 26013584
    [Abstract] [Full Text] [Related]

  • 5. First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.
    Laleu B, Gaggini F, Orchard M, Fioraso-Cartier L, Cagnon L, Houngninou-Molango S, Gradia A, Duboux G, Merlot C, Heitz F, Szyndralewiez C, Page P.
    J Med Chem; 2010 Nov 11; 53(21):7715-30. PubMed ID: 20942471
    [Abstract] [Full Text] [Related]

  • 6. The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle.
    Ellmark SH, Dusting GJ, Fui MN, Guzzo-Pernell N, Drummond GR.
    Cardiovasc Res; 2005 Feb 01; 65(2):495-504. PubMed ID: 15639489
    [Abstract] [Full Text] [Related]

  • 7. Peptide-based inhibitors of the phagocyte NADPH oxidase.
    El-Benna J, Dang PM, Périanin A.
    Biochem Pharmacol; 2010 Sep 15; 80(6):778-85. PubMed ID: 20510204
    [Abstract] [Full Text] [Related]

  • 8. Expression of nonphagocytic NADPH oxidase system in the ocular lens.
    Rao PV, Maddala R, John F, Zigler JS.
    Mol Vis; 2004 Feb 19; 10():112-21. PubMed ID: 14978478
    [Abstract] [Full Text] [Related]

  • 9. NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation.
    Gatto GJ, Ao Z, Kearse MG, Zhou M, Morales CR, Daniels E, Bradley BT, Goserud MT, Goodman KB, Douglas SA, Harpel MR, Johns DG.
    J Enzyme Inhib Med Chem; 2013 Feb 19; 28(1):95-104. PubMed ID: 22136506
    [Abstract] [Full Text] [Related]

  • 10. Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets.
    Jaquet V, Scapozza L, Clark RA, Krause KH, Lambeth JD.
    Antioxid Redox Signal; 2009 Oct 19; 11(10):2535-52. PubMed ID: 19309261
    [Abstract] [Full Text] [Related]

  • 11. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
    Guzik TJ, Harrison DG.
    Drug Discov Today; 2006 Jun 19; 11(11-12):524-33. PubMed ID: 16713904
    [Abstract] [Full Text] [Related]

  • 12. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase.
    Sorescu GP, Song H, Tressel SL, Hwang J, Dikalov S, Smith DA, Boyd NL, Platt MO, Lassègue B, Griendling KK, Jo H.
    Circ Res; 2004 Oct 15; 95(8):773-9. PubMed ID: 15388638
    [Abstract] [Full Text] [Related]

  • 13. NADPH oxidase inhibitors: new antihypertensive agents?
    Williams HC, Griendling KK.
    J Cardiovasc Pharmacol; 2007 Jul 15; 50(1):9-16. PubMed ID: 17666910
    [Abstract] [Full Text] [Related]

  • 14. The NOX toolbox: validating the role of NADPH oxidases in physiology and disease.
    Altenhöfer S, Kleikers PW, Radermacher KA, Scheurer P, Rob Hermans JJ, Schiffers P, Ho H, Wingler K, Schmidt HH.
    Cell Mol Life Sci; 2012 Jul 15; 69(14):2327-43. PubMed ID: 22648375
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of NADPH oxidase activity promotes differentiation of B16 melanoma cells.
    Zhao Y, Liu J, McMartin KE.
    Oncol Rep; 2008 May 15; 19(5):1225-30. PubMed ID: 18425380
    [Abstract] [Full Text] [Related]

  • 16. Peptide screen identifies a new NADPH oxidase inhibitor: impact on cell migration and invasion.
    Mousslim M, Pagano A, Andreotti N, Garrouste F, Thuault S, Peyrot V, Parat F, Luis J, Culcasi M, Thétiot-Laurent S, Pietri S, Sabatier JM, Kovacic H.
    Eur J Pharmacol; 2017 Jan 05; 794():162-172. PubMed ID: 27743884
    [Abstract] [Full Text] [Related]

  • 17. Role of NADPH oxidase in the apoptotic death of cultured cerebellar granule neurons.
    Coyoy A, Valencia A, Guemez-Gamboa A, Morán J.
    Free Radic Biol Med; 2008 Oct 15; 45(8):1056-64. PubMed ID: 18675340
    [Abstract] [Full Text] [Related]

  • 18. Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells.
    Jaulmes A, Sansilvestri-Morel P, Rolland-Valognes G, Bernhardt F, Gaertner R, Lockhart BP, Cordi A, Wierzbicki M, Rupin A, Verbeuren TJ.
    Thromb Res; 2009 Sep 15; 124(4):439-46. PubMed ID: 19540572
    [Abstract] [Full Text] [Related]

  • 19. p22phox-dependent NADPH oxidase activity is required for megakaryocytic differentiation.
    Sardina JL, López-Ruano G, Sánchez-Abarca LI, Pérez-Simón JA, Gaztelumendi A, Trigueros C, Llanillo M, Sánchez-Yagüe J, Hernández-Hernández A.
    Cell Death Differ; 2010 Dec 15; 17(12):1842-54. PubMed ID: 20523355
    [Abstract] [Full Text] [Related]

  • 20. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.
    Bedard K, Krause KH.
    Physiol Rev; 2007 Jan 15; 87(1):245-313. PubMed ID: 17237347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.